Morgan Stanley Meira G Tx Holdings PLC Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Morgan Stanley holds 339,598 shares of MGTX stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

339,598

Previous 213,635 58.96%

Holding current value

$1.93 Million

Previous $1.3 Million 76.94%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$5.71 - $8.25 $719,248 - $1.04 Million	125,963 Added 58.96%	339,598 $2.3 Million
Q4 2024 Feb 14, 2025	BUY	$4.03 - $7.1 $85,895 - $151,329	21,314 Added 11.08%	213,635 $1.3 Million
Q3 2024 May 14, 2025	BUY	$3.88 - $5.23 $352,800 - $475,553	90,928 Added 89.68%	192,321 $801,000
Q3 2024 Nov 14, 2024	BUY	$3.88 - $5.23 $352,800 - $475,553	90,928 Added 89.68%	192,321 $801,000
Q2 2024 May 14, 2025	SELL	$4.21 - $5.81 $472,538 - $652,126	-112,242 Reduced 52.54%	101,393 $426,000
Q2 2024 Oct 17, 2024	BUY	$4.21 - $5.81 $26,956 - $37,201	6,403 Added 6.74%	101,393 $426,000
Q2 2024 Aug 14, 2024	BUY	$4.21 - $5.81 $26,956 - $37,201	6,403 Added 6.74%	101,393 $426,000
Q1 2024 Oct 17, 2024	SELL	$5.78 - $7.33 $37,009 - $46,933	-6,403 Reduced 6.32%	94,990 $576,000
Q1 2024 Aug 16, 2024	SELL	$5.78 - $7.33 $159,007 - $201,648	-27,510 Reduced 22.46%	94,990 $576,000
Q1 2024 May 15, 2024	SELL	$5.78 - $7.33 $159,007 - $201,648	-27,510 Reduced 22.46%	94,990 $576,000
Q4 2023 Aug 16, 2024	BUY	$3.6 - $7.15 $75,985 - $150,915	21,107 Added 20.82%	122,500 $859,000
Q4 2023 Feb 13, 2024	BUY	$3.6 - $7.15 $135,558 - $269,233	37,655 Added 44.38%	122,500 $859,000
Q3 2023 Nov 15, 2023	SELL	$4.79 - $7.19 $86,354 - $129,621	-18,028 Reduced 17.52%	84,845 $416,000
Q2 2023 Aug 14, 2023	SELL	$5.19 - $8.07 $47,005 - $73,089	-9,057 Reduced 8.09%	102,873 $691,000
Q1 2023 May 15, 2023	BUY	$5.04 - $8.6 $108,113 - $184,478	21,451 Added 23.71%	111,930 $578,000
Q4 2022 Feb 14, 2023	BUY	$5.8 - $8.98 $180,536 - $279,520	31,127 Added 52.44%	90,479 $589,000
Q3 2022 Nov 14, 2022	SELL	$7.55 - $11.25 $52,819 - $78,705	-6,996 Reduced 10.54%	59,352 $500,000
Q2 2022 Oct 27, 2022	SELL	$6.8 - $14.23 $352,131 - $736,886	-51,784 Reduced 43.84%	66,348 $503,000
Q2 2022 Aug 15, 2022	SELL	$6.8 - $14.23 $352,131 - $736,886	-51,784 Reduced 43.84%	66,348 $503,000
Q1 2022 Oct 27, 2022	BUY	$13.42 - $23.38 $694,941 - $1.21 Million	51,784 Added 78.05%	118,132 $1.64 Million
Q1 2022 May 13, 2022	BUY	$13.42 - $23.38 $219,417 - $382,263	16,350 Added 16.06%	118,132 $1.64 Million
Q4 2021 Feb 14, 2022	BUY	$12.78 - $23.74 $436,948 - $811,670	34,190 Added 50.58%	101,782 $2.42 Million
Q3 2021 Nov 15, 2021	BUY	$11.73 - $16.08 $792,854 - $1.09 Million	67,592 New	67,592 $890,000

Others Institutions Holding MGTX

# of Institutions

119

Shares Held

47.3M

Call Options Held

159K

Put Options Held

38.4K

View Full List

About MeiraGTx Holdings plc

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $256M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

More about MGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account